Poseida Therapeutics, Inc. (PSTX)
NASDAQ: PSTX · Real-Time Price · USD
2.530
+0.060 (2.43%)
Nov 4, 2024, 4:00 PM EST - Market closed

Poseida Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2016
Period Ending
Jun '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2016
Revenue
88.4664.7130.4931.24--
Upgrade
Revenue Growth (YoY)
-43.55%-50.42%317.73%---
Upgrade
Cost of Revenue
156.78156.77152.9136.73103.52-
Upgrade
Gross Profit
-68.32-92.07-22.41-105.5-103.52-
Upgrade
Selling, General & Admin
38.9337.4437.5435.9223.0318.46
Upgrade
Research & Development
11.22----60.39
Upgrade
Operating Expenses
50.1537.4437.5435.9223.0378.85
Upgrade
Operating Income
-118.47-129.5-59.95-141.41-126.55-78.85
Upgrade
Interest Expense
-9.01-8.67-6.37-3.36-3.51-3.55
Upgrade
Interest & Investment Income
-----2
Upgrade
Other Non Operating Income (Expenses)
14.8214.852.8619.80.280.56
Upgrade
EBT Excluding Unusual Items
-112.67-123.32-63.46-124.97-129.78-79.84
Upgrade
Other Unusual Items
------6.68
Upgrade
Pretax Income
-112.67-123.32-63.46-124.97-129.78-86.53
Upgrade
Income Tax Expense
0.110.110.54---
Upgrade
Net Income
-112.77-123.43-64-124.97-129.78-86.53
Upgrade
Net Income to Common
-112.77-123.43-64-124.97-129.78-86.53
Upgrade
Shares Outstanding (Basic)
959072623613
Upgrade
Shares Outstanding (Diluted)
959072623613
Upgrade
Shares Change (YoY)
13.42%25.34%15.61%72.89%185.27%3.57%
Upgrade
EPS (Basic)
-1.19-1.37-0.89-2.01-3.61-6.86
Upgrade
EPS (Diluted)
-1.19-1.37-0.89-2.01-3.61-6.86
Upgrade
Free Cash Flow
0.21-95.23-30.7-105.18-130.24-69.67
Upgrade
Free Cash Flow Per Share
0.00-1.06-0.43-1.69-3.62-5.52
Upgrade
Gross Margin
-77.23%-142.29%-17.17%---
Upgrade
Operating Margin
-133.92%-200.15%-45.94%-452.69%--
Upgrade
Profit Margin
-127.48%-190.76%-49.05%-400.07%--
Upgrade
Free Cash Flow Margin
0.24%-147.18%-23.52%-336.70%--
Upgrade
EBITDA
-112.86-123.89-54.77-136.86-123.96-77.66
Upgrade
EBITDA Margin
-127.58%-191.47%-41.97%---
Upgrade
D&A For EBITDA
5.615.615.174.552.591.19
Upgrade
EBIT
-118.47-129.5-59.95-141.41-126.55-78.85
Upgrade
EBIT Margin
-133.92%-200.15%-45.94%---
Upgrade
Revenue as Reported
88.4664.7130.4931.24--
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.